A B S T R A C T Clearer definition of the recognitive structures of human T lymphocytes for antigens will be required to elucidate the molecular basis of diseases and immunological responses induced or regulated by normal or abnormal T-cell function. For this purpose we have investigated the cellular requirements for immune responses in vitro to trinitrophenyl-conjugated peripheral blood mononuclear cells. The responding cell was characterized as a T cell on the basis of rosetting with sheep erythrocytes. T-cell recognition of hapten in proliferative responses depended upon presentation of antigen in an appropriate stimulator-cell context. Neither autologous hapten-modified erythrocytes nor T cells restimulated responses of in vitro-primed lymphocytes. Moreover, hapten-conjugated non-T cells were more effective than modified unfractionated cells in restimulating proliferative responses. Both macrophages and non-T lymphocytes effectively restimulated hapten-conjugate responses.
Cell-mixing experiments indicated that the failure of haptenated T cells to stimulate proliferative responses was not because ofa lack offresh macrophages; these experiments suggested instead that T cells do not express appropriate structures necessary to present haptenic determinants in an immunogenic form. Hapten-modified T cells, however, were capable of inducing primed lymphocytes to become efficient cytotoxic effector cells, indicating that T-cell recognitive units for stimulation of proliferative and cytotoxic responses are different. These data support the concept that for induction of proliferative responses, human T cells recognize conventional antigens in association with HLA-D-region-encoded Ia-like molecules.
INTRODUCTION
Specific abnormalities of human T-cell activation or control of immune responses seem critically important in the pathogenesis of numerous diseases. The increasing recognition ofthe association of HLA antigens with a predisposition to certain diseases (1, 2) has focused urgent attention on elucidation of the function of major histocompatibility complex (MHC)1 genes in the pathogenesis of such disorders. Furthermore, the development and course of disease processes induced by immune responses to modifications in autologous cell surfaces may be controlled by genes within the MHC. An understanding, however, will first require a definition of the role of histocompatibility determinants in T-cell recognition. Examination of human in vitro proliferative and cytotoxic responses to hapten-modified autologous cells may allow a functional characterization of the autologous determinants involved in both normal and abnormal immune responses.
In the mouse, recognition of viruses (3), minor histocompatibility antigens (4) and haptenic determinants (5-7) by T cells is dependent upon the expression of autologous determinants controlled by the murine MHC, H-2. Thus, in vitro T-cell function is restricted in cytotoxic responses by H-2K and H-2D antigens, and in proliferative responses by H-2I-region-encoded Ia antigens. In vivo, immune T cells can only transfer resistance to virus-infected hosts ifH-2K or H-2D homology requirements are met (8) . On the other hand, resistance to mycobacterial infections are only conferred by T cells which share H-21-region tions has been shown to be critical in the presentation of both protein antigens and hapten-modified cell surface determinants to responder T cells (10) (11) (12) .
Recent studies in humans have demonstrated that cell-mediated cytotoxic responses to the Y male antigen (13), influenza-infected cells (14, 15) , and haptenmodified cells (16, 17) are constrained by HLA-A-or -Blocus antigens. In contrast, our previous data (18, 19) , recently confirmed by Thorsby and Nousiainen (20) Labware) . After incubation for 6 h at 37°C in a humidified, 5% CO2 atmosphere, 5'Cr-release was measured as previously described (22 with Tris/NH4Cl, and cells were washed twice with media. Unfractionated controls were treated in the same manner. The non-E-rosette population contained <8% E rosette-positive cells, >40% esterase-positive cells, and >60% C3 receptorbearing cells. To obtain a T cell-enriched population the Erosette fraction was rosetted a second time. The double E rosette-purified cells contained -85% E rosette-positive cells, <2% esterase-positive cells, <5% C3 receptor-bearing cells, and <2% surface immunoglobulin-positive cells. All populations were >95% viable as assessed by trypan blue. Macrophage-monocyte populations were isolated by a plastic dish adherence procedure. 50 million PBMC were incubated in 100 x 20-mm plastic Petri dishes (Falcon Labware) for 45 min at 37°C in a 5% CO2 incubator in 10 ml of RPMI 1640 with 10% autologous serum that had not been heat inactivated. Nonadherent cells were removed from Petri dishes by vigorously washing four times at 37°C with 7 ml of RPMI 1640 with 20% fetal calf serum. To recover adherent cells, Petri dishes were then incubated at 370C for 30 min in the presence of 3 mM of EDTA and then washed twice with Hanks' balanced salt solution at 40C. The recovered cells were >95% esterase positive and >95% viable. To control for possible adverse effects of EDTA treatment, both adherent and nonadherent cell populations were treated with EDTA in identical fashion in experiments in which adherent cells were isolated.
To obtain non-T lymphocytes, cells that did not adhere to plastic Petri dishes were first fractionated into E rosettepositive and -negative populations. E rosette-negative cells were then depleted of monocytes by passage thru Sephadex G-10 (Pharmacia Fine Chemicals Inc.) columns using a modification of the method of Ly and Mishell (27, 28) . The resultant population contained < 10% E rosette-positive cells, <5% esterase-positive cells, and >40% surface immunoglobulin-positive cells.
HLA typing. Typing for HLA-A-and -B-locus antigens was performed in the Methodist Hospital Tissue Typing Laboratory with standard serologic methods (29) . HLA-D-region specificities were similarly detected with B-cell typing procedures (DRw) (30) .
RESULTS
Characterization of human TNP-conjugate responder cells. The ability of human T cells to form rosettes with sheep erythrocytes was used to determine the responder cell in proliferative responses to hapten-modified cells. Unfractionated PBMC were sensitized to autologous hapten-modified cells and 3 wk later separated into E-rosette and non-E-rosette cell populations. As shown in Table I , the unfractionated, E rosette-positive and E rosette-negative primed responder cells were then restimulated with autologous PBMC which were either TNP-conjugated or unconjugated. The E rosette-positive cells were clearly better responders than the unfractionated cells. Conversely, the responses of the non-E-rosette cells were substantially reduced. The small response noted by the latter population may be explained by the residual contamination, mo8%, of E rosette-positive cells, although modest intrinsic responsiveness of the non-Erosette population was not ruled out. These experiments thus demonstrate that the cells which proliferated in response to hapten-conjugated PBMC were largely or exclusively T lymphocytes. Table III . Hapten-modified T cells (E-rosette fraction) were not effective stimulators. Moreover, hapten-modified non-T cells (non-E-rosette fraction), which contained both monocytes and non-T lymphocytes, restimulated proliferative responses more effectively than modified unfractionated cells.
The ineffectiveness of modified T cells to function as stimulators might be explained by a culture requirement for fresh macrophages. On the basis of nonspecific esterase staining, the E-rosette stimulator cell fraction contained <2% monocytes-macrophages whereas the non-E-rosette stimulator cell fraction possessed -50% monocytes-macrophages. Although the primed responder cells contained 25% esterasepositive cells, it is possible that accessory cell function in long-term cultures is defective. It was also possible that the inability of T cells to stimulate haptenconjugate proliferative responses could be explained by a suppressive mechanism. To address these questions, cell-mixing experiments were performed (Table  IV) . In these experiments, stimulator populations were comprised of equal concentrations of E-rosette and non-E-rosette cells that were either TNP-conjugated or unconjugated. The addition of non-E-rosette cells did not enhance the stimulatory capacity of TNP-modified E-rosette cells. Furthermore, the addition of E rosette- Purified plastic-adherent peripheral blood monocytes functioned effectively as hapten-conjugate stimulators (Table V) . This adherent monocyte population was, however, less stimulatory than unfractionated cells. Interestingly, the non-E-rosette fraction, which had been depleted of the adherent population, was more effective than the adherent monocytes in stimulating hapten-conjugate proliferative responses. Removal of most of the esterase-positive cells from the non-E-rqsette fraction by passage over Sephadex G-10 columns did not affect the stimulatory capacity. That is, a non-T-lymphocyte fraction, which contained <4% Table I. t Stimulator population contained equal concentration of E-rosette (ER) and non-E-rosette (NER) cells that were either TNP-conjugated or unconjugated.
Recognition of Hapten-Modified Cells esterase-positive cells, was as stimulatory as the non-E-rosette fraction, which contained over 40% esterase-positive cells, and was more stimulatory than the adherent population which contained over 95% esterase-positive cells. It was still possible, however, that the residual macrophage contamination was responsible for the ability of this fraction to stimulate. A titration analysis of the stimulator cell populations was therefore performed (Fig. 1) . A ninefold dilution of the non-T-lymphocyte stimulator cells, containing <400 monocytes, stimulated responses as great as non-T lymphocytes 6 non-E-rosette cells FIGURE 1 Titration analysis of proliferative responses to different hapten-conjugated subpopulations ofPBMC. Primed responder lymphocytes were restimulated with various concentrations of stimulator cells obtained as described in Table V. >95,000 purified monocytes. Furthermore, reduction of the monocyte stimulator-cell concentration demiionstrated that the initial concentration of these cells was not suppressive.
Requiremetnts for proliferative vs. cmytotoxic responses to hapten-modified cells. Our previous data demonstrated that optimal secondary proliferative responses of human lymphocytes to hapten-modified cells require HLA-D-region homology between responder and stimulator cells. On the other hand, Shaw et al. (17, 34) found that T cells primed to TNP-modified cells lysed modified allogeneic targets to the same extent as modified autologous targets, although partial HLA-A-and -B-locus restriction of cytotoxic responses was demonstrated by cold target-blocking studies. To determine whether the specificities involved in these two types of T cell-mediated responses were, in fact, different, and not readily explained by uncontrolled technical variables between laboratories, we compared proliferative and cytotoxic responses within the same experiment (Fig. 2) . Primed responder cells were restimulated with hapten-modified or unmodified autologous cells, allogeneic human cells that did not share any HLA determinants with the responder, or mouse cells. Although the modified allogeneic human cells restimulated only 30% of the proliferative response of modified autologous stimulators (Fig. 2, left panel) modified allogeneic cells were lysed as well or better than the modified autologous target cells (Fig. 2, right  panel) . TNP-modified murine cells did not stimulate either proliferative or cytotoxic responses, consistent with the specificity shown by other investigators (34) . Because human cytotoxic responses to haptenmodified cells did not appear to be related to the expression of HLA-D-region controlled antigens, we next investigated whether T cells could stimulate cytotoxic responses. Fig. 3 shows the proliferative and cytotoxic responses induced when primed responder cells were restimulated with either hapten-modified unfractionated cells or hapten-modified E-rosette cells. Unmodified non-E-rosette cells were added to all cultures to control for possible macrophage requirements. Recent experiments have shown that macrophages are necessary for accessory function but are not required for hapten presentation in murine TNP-conjugate cytotoxic responses (35) . Consistent with the data already presented, modified T cells did not effectively restimulate proliferative responses (Fig. 3A) . However, both effector cell populations, those stimulated with modified unfractionated and those with modified T cells, could extensively lyse hapten-modified targets (Fig. 3B) . Thus, although T cells could not stimulate proliferative responses, they could induce cytotoxic effector cells. non-T-cell lymphoid determinants. Thus, only those cell populations which express easily detectable amounts of D-region-encoded Ia-like antigens effectively restimulated proliferative responses of TNPconjugate-primed T lymphocytes. This finding extends our previous observations of preferential restimulation of autologous TNP-conjugate-primed cells with modified stimulators that share D-region determinants, DRw and Dw (18, 19) . A substantial proliferative response, however, was often generated by modified allogeneic stimulators that did not share detected histocompatibility antigens with the primed responder. The stimulatory capacity of modified allogeneic cells which do not share D-region determinants may be a result of extensive cross-reactivity between human histocompatibility antigens or of as yet undetected specificities. Because non-T lymphocytes which function as effective stimulators also express unique antigens encoded outside of HLA the influence of non-MHC antigens in the recognition of hapten must also be considered (36, 37) .
The role of macrophages in proliferative responses to TNP-conjugated cells has previously been studied by Thomas et al. (38) in the guinea pig. In accord with the data reported here, these investigators found that TNP-conjugated thymocytes and erythrocytes did not induce proliferative responses; addition of unmodified macrophages to TNP-modified T cells did not restore responses. Similarly, we found that the addition ofnonRecognition of Hapten-Modified Cells 973
Cytotoxkc Response E-rosette stimulator cells, which contain a high proportion of macrophages (-50%), had no effect on the net proliferative response to modified T cells. Addition of unmodified T cells to TNP-modified non-E-rosette cells also had no effect. These data militate against the likelihood that macrophage-culture effects, amplifier effects, and suppressor-cell mechanisms explain the failure of modified T cells to induce proliferative responses. Because modified T cells can induce cytotoxic effector cells, these results imply that T cells do not possess structures capable of presenting haptenic determinants to those T cells which respond in proliferative assays. The histocompatibility requirements for cytotoxic effector-cell function differ from those for proliferative responses. In the human, HLA-A-or -B-locus homology requirements between killer and target cells have been reported for cytotoxic responses generated against the Y male antigen (13), influenza-infected cells (14, 15) , and hapten-modified cells (16, 17) . In contrast, we and others have reported the importance of HLA-D-region determinants in the generation of human proliferative responses to haptens and other conventional antigens (18) (19) (20) (39) (40) (41) . In this study we have found that antigen presentation requirements for induction of cells capable of cytotoxic effector function also differ from those for proliferative responses. Nonactivated T cells, which do not express easily detectable amounts of D-region-encoded determinants, were capable of inducing secondary TNP-conjugate cytotoxic responses. Thus, the dichotomy between histocompatibility requirements for proliferative and cytotoxic responses is present for response induction as well as at the effector level.
The non-E-rosette population of cells that most effectively presents haptenic determinants is the same PBMC population that stimulates allogeneic mixed leukocyte reactions (42, 43) and autologous mixed leukocyte reactions (43) . The observation that glutaraldehyde fixation of TNP-modified cells abrogates the capacity to stimulate secondary proliferative responses is also consistent with previous observations in mixed leukocyte reactions (44) . Interestingly, cytotoxic responses to both autologous TNP-modified cells and allogeneic cells can be effectively induced with glutaraldehyde-fixed cells in the mouse (21, 44) . Thus the properties of antigenic determinants associated with the induction of proliferative responses differ from those for cytotoxic responses. These results provide further evidence that the distinction between "lymphocyte-defined" or class I molecules (HLA-D) and "serologically defined" or class II molecules (HLA-A and -B), initially demonstrated for reactions to allogeneic cells (45, 46) , applies to human immune responses to conventional antigens.
Both adherent monocytes and non-T lymphocytes effectively stimulated secondary TNP-conjugate proliferative responses. The non-T-lymphocyte population contains B cells and nonsurface-immunoglobulinbearing, non-T lymphocytes (null cells), both of which, in contrast to T cells, express Ia-like determinants (32, 33) . Additional studies will be required to ascertain whether B cells or null cells, or both, are capable of effective hapten-conjugate presentation. We found that adherent macrophages restimulated proliferative responses less well than either unfractionated cells or non-E-rosette cells. This finding suggests that it may be possible to distinguish between presentation of antigens by subpopulations of macrophages and other Ia-positive cells for development of proliferative responses. Experiments designed to test this hypothesis are in progress.
Lawrence (47) theorized almost two decades ago that delayed hypersensitivity reactions and autoimmune diseases may be expressions of homograft reactions undertaken by the host against certain of its tissues. For delayed hypersensitivity reactions it now appears likely that antigens are indeed recognized in association with autologous determinants. Proliferative responses of lymphocytes from human subjects sensitized in vivo by dinitrochlorobenzene skin painting are preferentially restimulated in vitro with autologous dinitrophenyl-modified cells (48) . Available data suggest that the proliferative responses in vitro are related in magnitude and specificity to delayed hypersensitivity reactions (49) (50) (51) . Investigations of both proliferative responses to hapten-conjugated cells (18) (19) (20) and to purified protein derivative (39) (40) (41) suggest that the autologous determinants involved in delayed hypersensitivity reactions are encoded in the HLA-D region. Haptenic determinants on soluble proteins or membrane fragments (52) 
